V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20213922 | 20129571 | 1.72 | 86.2 | null | 2020-08-17 | 2020-09-13 | Cetuximab + Oxaliplatin + MdG Maint | 2 | null | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100644538 |
| 20213924 | 20129572 | 1.7 | 54.8 | Curative (C) | 2019-05-22 | 2019-06-11 | CAPECITABINE + RT | 02 | null | CAPECITABINE + RT | 101376638 |
| 20213925 | 20129573 | 1.72 | 108 | Palliative (P) | 2018-07-30 | 2018-07-30 | EOX | 02 | N | EOX | 101691490 |
| 20213926 | 20129574 | 1.69 | 80.8 | Adjuvant (A) | 2019-10-16 | 2019-10-22 | Cetuximab + FOLFIRI cycle 2 onwards | 2 | N | CETUXIMAB + IRINOTECAN + MDG | 100548328 |
| 20213929 | 20129575 | 1.7 | 70 | Adjuvant (A) | 2016-08-25 | 2016-09-03 | EOX | 02 | N | EOX | 101191174 |
| 20213931 | 20129576 | null | 95.1 | Curative (C) | 2019-03-17 | 2019-03-19 | Trial Unspecified | 02 | N | TRIAL | 100954852 |
| 20213932 | 20129577 | 1.69 | 76.7 | Palliative (P) | 2018-07-01 | 2018-07-19 | EOX | 02 | N | CAPECITABINE + RT | 100206870 |
| 20213933 | 20129578 | 1.56 | 56 | null | 2017-05-16 | 2017-06-15 | EOX | 02 | null | OXALIPLATIN + RALTITREXED | 101123551 |
| 20213935 | 20129579 | null | 78.3 | Palliative (P) | 2018-07-27 | 2018-08-10 | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101186990 |
| 20213936 | 20129580 | 1.64 | 76.5 | Palliative (P) | 2017-05-07 | 2017-06-04 | EOX | 2 | N | CAPECITABINE + RT | 100773795 |
| 20213937 | 20129581 | 1.69 | 40.4 | null | 2017-11-22 | 2017-12-08 | Capecitabine 5days + RT | 2 | N | CAPECITABINE + RT | 101778503 |
| 20213938 | 20129582 | 1.53 | 80.8 | Neo-adjuvant (N) | null | null | EOX | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100039774 |
| 20213940 | 20129583 | 1.69 | 72.05 | null | 2017-12-05 | 2017-12-21 | EOX | N | null | CAPECITABINE + RT | 100431809 |
| 20213941 | 20129584 | 1.81 | 90 | Palliative (P) | 2017-01-28 | 2017-02-07 | EOX | 02 | null | EOX | 101140170 |
| 20213942 | 20129585 | 1.72 | 57.05 | Neo-adjuvant (N) | 2019-12-13 | 2019-12-21 | EOX | 01 | N | TRIAL | 100788142 |
| 20213943 | 20129586 | 1.51 | 76.3 | Adjuvant (A) | 2016-07-08 | 2016-07-08 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 101641781 |
| 20213944 | 20129587 | 1.6 | 94.1 | Palliative (P) | 2018-07-04 | 2018-07-04 | EOX | 02 | N | EOX | 101145318 |
| 20213945 | 20129588 | 1.81 | 73.9 | Palliative (P) | 2018-12-29 | 2018-12-30 | EOX | 02 | N | OXALIPLATIN + RALTITREXED | 101695521 |
| 20213948 | 20129589 | 1.55 | 68.4 | null | 2021-06-14 | 2021-06-24 | IRINOTECAN + MDG + PANITUMUMAB | N | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100241609 |
| 20213949 | 20129590 | 1.6 | 78 | Adjuvant (A) | 2018-12-21 | 2019-01-08 | EOX | 2 | N | CETUXIMAB + IRINOTECAN + MDG | 100541208 |
| 20213950 | 20129591 | 1.83 | 46.9 | null | 2019-01-01 | 2019-01-08 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 02 | null | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101611032 |
| 20213955 | 20129592 | 1.84 | 73.3 | Palliative (P) | 2019-10-02 | 2019-10-20 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 100881141 |
| 20213957 | 20129593 | null | null | Palliative (P) | 2016-11-06 | 2016-12-27 | EOX | N | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100528369 |
| 20213959 | 20129594 | 1.63 | 130.7 | 03 | 2020-01-25 | 2020-01-28 | Sorafenib | 02 | null | SORAFENIB | 101717821 |
| 20213960 | 20129595 | 1.82 | 58 | Neo-adjuvant (N) | 2017-08-04 | 2017-09-03 | EOX | 02 | null | TRIAL | 100422234 |
| 20213961 | 20129596 | 1.5 | null | null | 2017-04-10 | 2017-04-15 | Sorafenib | 02 | null | SORAFENIB | 100547992 |
| 20213962 | 20129597 | 1.85 | 54.4 | Curative (C) | 2019-05-21 | 2019-06-25 | EOX | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101174116 |
| 20213963 | 20129598 | 1.75 | 108.4 | Curative (C) | 2019-02-13 | 2019-02-16 | Cetuximab + Oxaliplatin + MdG Maint | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100502191 |
| 20213964 | 20129599 | 1.65 | 84 | Palliative (P) | 2020-03-18 | 2020-04-22 | CETUXIMAB + OXALIPLATIN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100897811 |
| 20213965 | 20129600 | 1.57 | 0 | Adjuvant (A) | 2019-11-15 | 2019-11-30 | EOX | N | N | EOX | 101222610 |
| 20213966 | 20129601 | 1.72 | 99.7 | Curative (C) | 2019-09-12 | 2019-10-11 | Sorafenib | 02 | Y | SORAFENIB | 101042401 |
| 20213967 | 20129602 | 1.84 | 73.5 | Neo-adjuvant (N) | 2017-07-08 | 2017-07-08 | EOX | 02 | N | EOX | 100611773 |
| 20213968 | 20129603 | 1.71 | 51.5 | Palliative (P) | 2019-11-10 | 2019-11-10 | Capecitabine 35days + RT | 02 | Y | CAPECITABINE + RT | 100042613 |
| 20213970 | 20129604 | 1.61 | 56 | Palliative (P) | 2020-02-11 | 2020-02-19 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100927406 |
| 20213971 | 20129605 | 1.62 | 73.4 | Curative (C) | 2019-01-02 | 2019-01-02 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100541274 |
| 20213972 | 20129606 | 1.78 | 89.9 | null | 2019-04-27 | 2019-10-21 | EOX | 02 | null | OXALIPLATIN + RALTITREXED | 101055746 |
| 20213974 | 20129607 | 1.76 | 80.4 | null | 2019-06-06 | 2019-07-08 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 02 | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101542634 |
| 20213978 | 20129608 | 1.64 | 76.7 | Palliative (P) | 2019-12-23 | 2019-12-24 | Sorafenib | 02 | Y | SORAFENIB | 101689185 |
| 20213979 | 20129609 | 1.79 | 90 | Palliative (P) | 2016-08-21 | 2016-08-27 | EOX | 02 | N | EOX | 100736911 |
| 20213981 | 20129610 | 1.82 | 99 | Palliative (P) | 2021-08-14 | 2021-11-05 | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101359074 |
| 20213986 | 20129611 | 1.66 | 91 | Adjuvant (A) | null | 2018-08-24 | EOX | N | N | SORAFENIB | 101060303 |
| 20213987 | 20129612 | 1.7 | 89.3 | 03 | 2016-01-18 | 2016-06-13 | EOX | 02 | N | CETUXIMAB + IRINOTECAN + MDG | 101306918 |
| 20213989 | 20129613 | 1.78 | 75.85 | Adjuvant (A) | 2018-03-11 | 2018-03-11 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 99 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100571435 |
| 20213990 | 20129614 | 1.57 | 51.4 | null | 2019-11-13 | 2019-11-21 | Cetuximab + FOLFIRI cycle1 | N | null | CETUXIMAB + IRINOTECAN + MDG | 101798496 |
| 20213992 | 20129615 | 1.6 | 52.1 | Palliative (P) | 2019-02-05 | 2019-02-05 | Cetuximab + FLUOROURACIL + FOLINIC ACID + OXALIPLATIN | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101036397 |
| 20213993 | 20129616 | 1.71 | 75 | Palliative (P) | 2019-08-28 | 2019-08-28 | EOX | 1 | N | CETUXIMAB + IRINOTECAN + MDG | 101767342 |
| 20213996 | 20129617 | 1.58 | 101.5 | Adjuvant (A) | 2018-08-21 | 2018-09-09 | Cetuximab + FLUOROURACIL + OXALIPLATIN | N | N | CETUXIMAB + IRINOTECAN + MDG | 101572251 |
| 20214001 | 20129618 | 1.72 | 79 | Palliative (P) | 2018-05-13 | 2018-05-22 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101362677 |
| 20214002 | 20129619 | 1.82 | 62.9 | Adjuvant (A) | 2019-03-25 | 2019-05-20 | EOX | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100792424 |
| 20214004 | 20129620 | 1.76 | 79 | Palliative (P) | 2020-10-22 | 2020-10-22 | EOX | N | N | CETUXIMAB + IRINOTECAN + MDG | 101459084 |